MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The role of microRNAs (miRNAs) in cancer development is increasingly recognized.
• The specific function of miR-339 in human gastric cancer (GC) has not been fully elucidated.
• Gastric cancer remains a significant global health challenge, necessitating novel therapeutic targets.

Purpose of the Study:

• To investigate the expression and function of miR-339 in human gastric cancer.
• To identify potential molecular targets regulated by miR-339 in GC.
• To explore the therapeutic potential of miR-339 restoration in GC treatment.

Main Methods:

• Quantitative analysis of miR-339 expression in primary GC tissues and cell lines.
• In vitro and in vivo experiments to assess the effects of miR-339 overexpression on GC cell behavior (proliferation, migration, invasion, tumorigenicity).
• Target validation using luciferase reporter assays and Western blotting to confirm NOVA1 as a direct target of miR-339.

Main Results:

• miR-339 expression was significantly downregulated in primary GC tissues compared to normal tissues.
• Overexpression of miR-339 suppressed GC cell proliferation, migration, invasion, and in vivo tumorigenicity.
• NOVA1 was identified as a direct target of miR-339, and its restoration partially reversed the inhibitory effects of miR-339.
• Evidence suggests that epigenetic modifications may influence miR-339 expression levels.

Conclusions:

• miR-339 functions as a tumor suppressor in gastric carcinogenesis.
• Targeting NOVA1 by miR-339 is a key mechanism underlying its tumor-suppressive role.
• Restoration of miR-339 represents a promising therapeutic strategy for gastric cancer.